Authors
Loading...
Study explores BLZF1's impact on lung adenocarcinoma, indicating its promise as a diagnostic biomarker.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: